Source: Virtual Congress 2021 – Long COVID - 19



Rating:

Share or cite this content

Citations should be made in the following way:
W. JELASSI (TUNIS, Tunisia), A. Hedhli (TUNIS, Tunisia), C. Echeikh (TUNIS, Tunisia), M. Mjid (TUNIS, Tunisia), Y. Ouahchi (TUNIS, Tunisia), S. Merai (TUNIS, Tunisia), S. Toujani (TUNIS, Tunisia), B. Dhahri (TUNIS, Tunisia). Insomnia in COVID-19 survivors: prevalence, severity and associated factors. 1165

Member's Comments

No comment yet.

Related content which might interest you: Anxiety and depression in COPD patients: prevalence and risk factors Source: Eur Respir J 2004; 24: Suppl. 48, 293s Year: 2004 Snoring in preschool children: prevalence, severity and risk factors Source: Eur Respir J 2008; 31: 326-333 Year: 2008 Sleep disorder level in stroke patients and related factors Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Prevalence and risk factors of depression in patients with COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Snoring in schoolchildren: prevalence and risk factors Source: International Congress 2018 – Insights in primary ciliary dyskinesia, asthma and lung function testing Year: 2018 Prevalence of COPD and comorbidity Source: Eur Respir Mon 2013; 59: 1-12 Year: 2013 Prevalence of anxiety and depression in COPD: are females at higher risk? Source: Eur Respir J 2005; 26: Suppl. 49, 514s Year: 2005 Impact of psychological factors on prevalence of respiratory symptoms Source: Eur Respir J 2004; 24: Suppl. 48, 602s Year: 2004 Obesity in pediatric asthma: prevalence and impact on severity Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017 Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Treatable traits in the NOVELTY study: prevalence, patterns and relationship with physician-assessed severity Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021 Prevalence and risk factors of co-morbidities in subjects with mild and moderate COPD detected by screening Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 Incidence of asthma and net change in symptoms in relation to changes in obesity Source: Eur Respir J 2006 Oct 01;28(4):763-771 Year: 2006 Clinical characteristics and related risk factors of depression in patients with early COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 COVID-19 prevalence, risk factors and outcomes in COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Aspirin-induced asthma is strongly associated with obesity: Large population study on prevalence and risk factors Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study Source: ERJ Open Res, 6 (2) 00300-2019; 10.1183/23120541.00300-2019 Year: 2020 Risk factors for multimorbidity in wheezing children: role of the phenotype Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep? Year: 2017 TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma Source: Eur Respir J 2006; 28: 1145-1155 Year: 2006 Multidimensional fatigue in pulmonary hypertension: prevalence, severity and predictors Source: ERJ Open Res, 4 (1) 00079-2017; 10.1183/23120541.00079-2017 Year: 2018